MENU
INCY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Incyte (INCY) Ownership - Who owns Incyte?
Incyte focuses on the discovery and development of small-molecule drugs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.79B
P/E Ratio
403.67
Total Cash
2.16B
Projected Growth
0.39
Total Debt
43.54M
Revenue
4.24B
Risk (Beta)
0.77
Dividend Yield
N/A
Total Cash/Share
11.15
Total Debt/Equity
N/A
Revenue/Share
20.15 USD as % of share price
Fundamentals
INCY
Capitalization
11.8B
P/E Ratio
403.67
Risk (Beta)
0.77
Dividend Yield
N/A
Total Cash
2.16B
Total Cash/Share
11.15
Total Debt
43.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.39
Revenue/Share (as % of the share price)
20.15%
Revenue
4.24B
ROE
N/A
Book Value
3.45B
P/B Ratio
3.40
Cash Flow
N/A
Earnings
0.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
193K
Current Ratio
1.97
Current Revenue Per Employee
450400.47
Dividends Per Share - Security
N/A
EBITDA
408M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.49
Revenue To Assets
0.53
Shares Held By Institutions
28.9B
Shares Outstanding - Current
194M
Total Liabilities
2B
Total Volume MTD
N/A
Value
-1
Gain YTD
-11.814
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com